Financial Volatility and Investment Dynamics in the Pharmaceutical Sector: Evidence from the Covid-19 Pandemic

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F75081431%3A_____%2F25%3A00002897" target="_blank" >RIV/75081431:_____/25:00002897 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/61989100:27510/25:10258801

Výsledek na webu

<a href="https://pjms.zim.pcz.pl/article/551759/en" target="_blank" >https://pjms.zim.pcz.pl/article/551759/en</a>

DOI - Digital Object Identifier

—

Jazyk výsledku

angličtina

Název v původním jazyce

Financial Volatility and Investment Dynamics in the Pharmaceutical Sector: Evidence from the Covid-19 Pandemic

Popis výsledku v původním jazyce

This study aims to analyze the financial impact of the COVID-19 pandemic on the pharmaceutical sector by assessing market volatility, stock performance, and investment behavior across different pandemic waves. It provides a novel perspective by examining the different financial responses of major pharmaceutical companies, Johnson and Johnson, Pfizer, and Moderna, over 949 trading days (March 2019-December 2022). Using statistical tools such as standard deviation and kurtosis, the study identifies volatility patterns and extreme price movements before, during, and after the pandemic. The results show that the first and fourth waves had the highest market volatility, influenced by vaccine development, regulatory decisions and changing investor sentiment. While short-term financial gains were significant, long-term profitability was challenged by market corrections and policy constraints. This study contributes to the literature by providing insights into crisis-driven financial instability and highlights the need for risk aware investment strategies in the pharmaceutical sector.

Název v anglickém jazyce

Financial Volatility and Investment Dynamics in the Pharmaceutical Sector: Evidence from the Covid-19 Pandemic

Popis výsledku anglicky

This study aims to analyze the financial impact of the COVID-19 pandemic on the pharmaceutical sector by assessing market volatility, stock performance, and investment behavior across different pandemic waves. It provides a novel perspective by examining the different financial responses of major pharmaceutical companies, Johnson and Johnson, Pfizer, and Moderna, over 949 trading days (March 2019-December 2022). Using statistical tools such as standard deviation and kurtosis, the study identifies volatility patterns and extreme price movements before, during, and after the pandemic. The results show that the first and fourth waves had the highest market volatility, influenced by vaccine development, regulatory decisions and changing investor sentiment. While short-term financial gains were significant, long-term profitability was challenged by market corrections and policy constraints. This study contributes to the literature by providing insights into crisis-driven financial instability and highlights the need for risk aware investment strategies in the pharmaceutical sector.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

50200 - Economics and Business

Projekt

—

Návaznosti

V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Rok uplatnění

2025

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Polish Journal of Management Studies

ISSN

2081-7452

e-ISSN

—

Svazek periodika

31

Číslo periodika v rámci svazku

1

Stát vydavatele periodika

PL - Polská republika

Počet stran výsledku

21

Strana od-do

178-198

Kód UT WoS článku

001522180900010

EID výsledku v databázi Scopus

—